BSECompany Update4d ago · 4 Aug 2026, 01:58 pm
Please find attached the Q1 FY 27 Investor Presentation
Morepen Laboratories Ltd · 500288
✦ AI Summary▲ PositiveResults
Morepen Laboratories Ltd has released its Q1 FY 27 Investor Presentation, highlighting a 34% YoY increase in revenue, 207% YoY increase in EBITDA, and 394% YoY increase in PAT. The company attributes this performance to operational execution and commercial validation of its Morepen 2.0 strategy.
Analysis Scores
Earnings Impact8/10
Growth Catalyst6/10
Governance Concern2/10
Regulatory Risk1/10
Balance Sheet Risk3/10
Liquidity Impact9/10
Market Sentiment8/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Morepen Laboratories Ltd - 500288 - Announcement under Regulation 30 (LODR)-Investor Presentation